InvestorsHub Logo
Followers 261
Posts 19732
Boards Moderated 0
Alias Born 10/03/2004

Re: eddiebali post# 20956

Tuesday, 01/15/2013 12:42:18 AM

Tuesday, January 15, 2013 12:42:18 AM

Post# of 403077
That's not at all true. CTIX is less than 4 years from market, and they are helping patients right now. When they advance to Phase 2/3, they will help another 300 or so patients.

I know there are many too timid or lacking the information to make the call, but know that Kevetrin will be a success. As a poster pointed out, the proof of concept and efficacy studies were not mice with cancer. They were specially bred mice with human tissue xenografts of human cancer tumors. It worked on these mice with a very low toxicity profile. It will work, and is working, on humans in much the same way.

Ctix is at least 8 to 10 years from bringing any relief to cancer patients.


It's RALLY time!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News